Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

H Gardner

Showing results (541-550 of 569) with videos related to

Pageof 57
Sort By:
Biorxiv : the Preprint Server for Biology|December 15, 2025
Use of High Pressure NMR Spectroscopy to Rapidly Identify Proteins with Internal Ligand-Binding VoidsDonald Gagné, Roksana Azad, James M Aramini, et al.
Stem Cells (Dayton, Ohio)|December 22, 1999
Pharmacokinetics and hematological effects of the PEGylated thrombopoietin peptide mimetic GW395058 in rats and monkeys after intravenous or subcutaneous administrationM de Serres, R L Yeager, J E Dillberger, et al.
The American Journal of Cardiology|July 1, 1991
Percutaneous transluminal coronary angioplasty in octogenarians as an effective therapy for angina pectorisJ D Jackman, F I Navetta, J E Smith, et al.
The American Journal of Cardiology|March 23, 2000
Timing of and risk factors for myocardial ischemic events after percutaneous coronary intervention (IMPACT-II). Integrilin to Minimize Platelet Aggregation and Coronary ThrombosisM C Thel, R M Califf, B E Tardiff, et al.
Journal of Adolescent and Young Adult Oncology|October 3, 2014
Barriers to the Use of Psychosocial Support Services Among Adolescent and Young Adult Survivors of Pediatric CancerMolly H Gardner, Margaux J Barnes, Shilpa Bopanna, et al.
Physical Review Letters|October 2, 2009
Stability of a shock-decelerated ablation frontY Aglitskiy, M Karasik, A L Velikovich, et al.
Journal of Medicinal Chemistry|July 31, 2015
Isoform-Selective and Stereoselective Inhibition of Hypoxia Inducible Factor-2Thomas H Scheuermann, Daniel Stroud, Christopher E Sleet, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|June 25, 2009
Efficacy of everolimus (RAD001) in patients with advanced NSCLC previously treated with chemotherapy alone or with chemotherapy and EGFR inhibitorsJ-C Soria, F A Shepherd, J-Y Douillard, et al.
Nature Chemical Biology|February 26, 2013
Allosteric inhibition of hypoxia inducible factor-2 with small moleculesThomas H Scheuermann, Qiming Li, He-Wen Ma, et al.
Journal of Medicinal Chemistry|February 1, 2013
Development of inhibitors of the PAS-B domain of the HIF-2α transcription factorJamie L Rogers, Liela Bayeh, Thomas H Scheuermann, et al.
Pageof 57

Showing results (541-550 of 569) with videos related to

Sort By:
Pageof 57
Biorxiv : the Preprint Server for Biology|December 15, 2025
Use of High Pressure NMR Spectroscopy to Rapidly Identify Proteins with Internal Ligand-Binding VoidsDonald Gagné, Roksana Azad, James M Aramini, et al.
Stem Cells (Dayton, Ohio)|December 22, 1999
Pharmacokinetics and hematological effects of the PEGylated thrombopoietin peptide mimetic GW395058 in rats and monkeys after intravenous or subcutaneous administrationM de Serres, R L Yeager, J E Dillberger, et al.
The American Journal of Cardiology|July 1, 1991
Percutaneous transluminal coronary angioplasty in octogenarians as an effective therapy for angina pectorisJ D Jackman, F I Navetta, J E Smith, et al.
The American Journal of Cardiology|March 23, 2000
Timing of and risk factors for myocardial ischemic events after percutaneous coronary intervention (IMPACT-II). Integrilin to Minimize Platelet Aggregation and Coronary ThrombosisM C Thel, R M Califf, B E Tardiff, et al.
Journal of Adolescent and Young Adult Oncology|October 3, 2014
Barriers to the Use of Psychosocial Support Services Among Adolescent and Young Adult Survivors of Pediatric CancerMolly H Gardner, Margaux J Barnes, Shilpa Bopanna, et al.
Physical Review Letters|October 2, 2009
Stability of a shock-decelerated ablation frontY Aglitskiy, M Karasik, A L Velikovich, et al.
Journal of Medicinal Chemistry|July 31, 2015
Isoform-Selective and Stereoselective Inhibition of Hypoxia Inducible Factor-2Thomas H Scheuermann, Daniel Stroud, Christopher E Sleet, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|June 25, 2009
Efficacy of everolimus (RAD001) in patients with advanced NSCLC previously treated with chemotherapy alone or with chemotherapy and EGFR inhibitorsJ-C Soria, F A Shepherd, J-Y Douillard, et al.
Nature Chemical Biology|February 26, 2013
Allosteric inhibition of hypoxia inducible factor-2 with small moleculesThomas H Scheuermann, Qiming Li, He-Wen Ma, et al.
Journal of Medicinal Chemistry|February 1, 2013
Development of inhibitors of the PAS-B domain of the HIF-2α transcription factorJamie L Rogers, Liela Bayeh, Thomas H Scheuermann, et al.
Pageof 57